SOMERSET, N.J., Nov. 08, 2024 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced its operating results for the third quarter ended September 30, 2024.
Jon Wilk, President and CEO of CompoSecure, commented: “We are very pleased with our third quarter performance which included double-digit growth for both Net Sales and Adjusted EBITDA. The quarter was driven by strong international execution, continued growth of new programs, and the growing adoption of our innovative payment cards. I am also happy to announce that we signed a two-year contract extension with Capital One.”
“Although we are reporting a GAAP Net Loss for the quarter, this was entirely driven by the significant improvement in our stock price this quarter, which impacts the valuation of non-cash items. Importantly, our Adjusted Net Income was up 18% compared to the year-ago period, which we believe more accurately reflects our operating performance.”
Mr. Wilk continued: “We are also enhancing our capabilities to drive accretive M&A and remain focused on strategic investments in our business. To support this growth, we are revising our Adjusted EBITDA guidance for the year to account for additional investments aimed at accelerating our momentum.”
Dave Cote, CompoSecure’s Executive Chairman, added: “As we embark on this next chapter, I want to express how excited I am about our long-term opportunities as well as our challenges ahead. We were attracted to the business because it hit the six hot buttons we used to evaluate acquisitions at Honeywell: Great position, good industry, technology differentiator, organic and inorganic sales growth, and margin expansion. That being said, this is a pivotal time for the company, and we are committed to building a culture centered on high performance, improving efficiency through the CompoSecure Operating System, reinvigorating organic growth, and driving accretive M&A. That work will require investment and you will see that reflected in our full year estimate.”
Financial Highlights (Q3 2024 vs. Q3 2023)
Liquidity and Capital Structure
Balance Sheet: At September 30, 2024, CompoSecure had $52.7 million of cash and cash equivalents and $330.0 million of total debt, which included $200.0 million of term loan and $130.0 million of exchangeable notes. This compares to cash and cash equivalents of $41.2 million and total debt of $340.3 million at December 31, 2023, and cash and cash equivalents of $23.8 million and total debt of $345.0 million at September 30, 2023. CompoSecure’s secured debt leverage ratio was 1.06x at September 30, 2024 compared to 1.39x at December 31, 2023 and 1.48x at September 30, 2023.
Shares Outstanding: On September 17, 2024, Resolute Holdings and its affiliated vehicles (“Resolute”) completed the acquisition of a majority interest in CompoSecure through stock purchase agreements among Resolute and certain selling shareholders. In the transaction, the selling shareholders exchanged all of their Class B units for Class A shares and Resolute acquired 49.3 million Class A shares, representing approximately 60% of CompoSecure’s outstanding shares. At September 30, 2024, CompoSecure had 82.7 million shares outstanding all of which were Class A shares, with the increase resulting from the Resolute Holdings transaction.
Exchangeable Notes
Additional Highlights
2024 Financial Outlook
CompoSecure is revising its full year Net Sales guidance to $418-$424 million (previously $418-$428 million) and its Adjusted EBITDA guidance to $148-$151 million (previously $150-157 million) to reflect investments for future growth.
Conference Call
CompoSecure will host a conference call and live audio webcast today at 8:30 a.m. Eastern Time to discuss its financial and operational results, followed by a question-and-answer period.
Date: Friday, November 8, 2024
Time: 8:30 a.m. Eastern Time
Dial-in registration link
Live webcast registration link
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
A live webcast and replay of the conference call will be available on the investor relations section of CompoSecure’s website at https://ir.composecure.com/news-events/events.
About CompoSecure
Founded in 2000, CompoSecure (Nasdaq: CMPO) is a technology partner to market leaders, fintech’s and consumers enabling trust for millions of people around the globe. The company combines elegance, simplicity and security to deliver exceptional experiences and peace of mind in the physical and digital world. CompoSecure’s innovative payment card technology and metal cards with Arculus security and authentication capabilities deliver unique, premium branded experiences, enable people to access and use their financial and digital assets, and ensure trust at the point of a transaction. For more information, please visit www.CompoSecure.com and www.GetArculus.com.
Forward-Looking Statements
This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management. Although CompoSecure believes that its plans, intentions, and expectations reflected in or suggested by these forward-looking statements are reasonable, CompoSecure cannot assure you that it will achieve or realize these plans, intentions, or expectations. Forward-looking statements are inherently subject to risks, uncertainties, and assumptions. Generally, statements that are not historical facts, including statements concerning CompoSecure’s possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. In some instances, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “will,” “should,” “seeks,” “plans,” “scheduled,” “anticipates” or “intends” or the negatives of these terms or variations of them or similar terminology. Forward-looking statements are not guarantees of performance. You should not put undue reliance on these statements which speak only as of the date hereof. You should understand that the following important factors, among others, could affect CompoSecure’s future results and could cause those results or other outcomes to differ materially from those expressed or implied in CompoSecure’s forward-looking statements: the ability of CompoSecure to diversify its business and customer base and to achieve enhancements in organic growth and operational efficiency, including for any future acquired companies; the ability of CompoSecure to create value for its shareholders and generate robust free cash flow; the ability of CompoSecure to grow and manage growth profitably, maintain relationships with customers, compete within its industry and retain its key employees; the possibility that CompoSecure may be adversely impacted by other global economic, business, competitive and/or other factors; the outcome of any legal proceedings that may be instituted against CompoSecure or others; future exchange and interest rates; and other risks and uncertainties, including those under “Risk Factors” in filings that have been made or will be made with the Securities and Exchange Commission. CompoSecure undertakes no obligations to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Use of Non-GAAP Financial Measures
This press release may include certain non-GAAP financial measures that are not prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and that may be different from non-GAAP financial measures used by other companies. CompoSecure believes EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow are useful to investors in evaluating CompoSecure’s financial performance. CompoSecure uses these measures internally to establish forecasts, budgets and operational goals to manage and monitor its business, as well as evaluate its underlying historical performance and/or to measure incentive compensation, as we believe that these non-GAAP financial measures depict the true performance of the business by encompassing only relevant and controllable events, enabling CompoSecure to evaluate and plan more effectively for the future. Due to the forward-looking nature of the financial guidance included above, specific quantification of the charges excluded from the non-GAAP financial measures included in such financial guidance, including with respect to depreciation, amortization, interest, and taxes, that would be required to reconcile the non GAAP financial measures included in such financial guidance to GAAP measures are not available, so it is not feasible to provide accurate forecasted non-GAAP reconciliations without unreasonable effort. Consequently, no disclosure of estimated comparable GAAP measures is included, and no reconciliation of the forward-looking non-GAAP financial measures is included. In addition, CompoSecure’s debt agreements contain covenants that use a variation of these measures for purposes of determining debt covenant compliance. CompoSecure believes that investors should have access to the same set of tools that its management uses in analyzing operating results. EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow should not be considered as measures of financial performance under U.S. GAAP, and the items excluded from EBITDA, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Free Cash Flow are significant components in understanding and assessing CompoSecure’s financial performance. Accordingly, these key business metrics have limitations as an analytical tool. They should not be considered as an alternative to net income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flows from operating activities as a measure of CompoSecure’s liquidity and may be different from similarly titled non-GAAP measures used by other companies. Please refer to the tables below for the reconciliation of GAAP measures to these non-GAAP measures.
Corporate Contact
Anthony Piniella
Head of Communications, CompoSecure
(917) 208-7724
apiniella@composecure.com
Investor Relations Contact
Sean Mansouri, CFA
Elevate IR
(720) 330-2829
CMPO@elevate-ir.
| Condensed Consolidated Balance Sheet Data (in thousands) | |||||||
| September 30, 2024 | December 31, 2023 | ||||||
| Unaudited | |||||||
| ASSETS | |||||||
| CURRENT ASSETS | |||||||
| Cash and cash equivalents | $ | 52,674 | $ | 41,216 | |||
| Accounts receivable, net | 43,799 | 40,488 | |||||
| Inventories | 55,090 | 52,540 | |||||
| Prepaid expenses and other current assets | 5,248 | 5,133 | |||||
| Total current assets | 156,811 | 139,377 | |||||
| Property and equipment, net | 23,062 | 25,212 | |||||
| Right of use assets, net | 5,929 | 7,473 | |||||
| Deferred tax asset | 245,102 | 23,697 | |||||
| Derivative asset - interest rate swap | 2,775 | 5,258 | |||||
| Deposits and other assets | 1,762 | 24 | |||||
| Total assets | $ | 435,441 | $ | 201,041 | |||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | |||||||
| CURRENT LIABILITIES | |||||||
| Accounts payable | 9,692 | 5,193 | |||||
| Accrued expenses | 13,473 | 11,986 | |||||
| Commission payable | 2,967 | 4,429 | |||||
| Bonus payable | 7,732 | 5,616 | |||||
| Current portion of long-term debt | 10,000 | 10,313 | |||||
| Current portion of lease liabilities | 2,070 | 1,948 | |||||
| Current portion of earnout liability | 18,527 | 60 | |||||
| Current portion of tax receivable agreement liability | 122 | 1,425 | |||||
| Total current liabilities | 64,583 | 40,970 | |||||
| Long-term debt, net of deferred finance costs | 188,149 | 198,331 | |||||
| Convertible notes | 128,220 | 127,832 | |||||
| Derivative liability - convertible notes redemption make-whole provision | — | 425 | |||||
| Warrant liability | 84,505 | 8,294 | |||||
| Lease liabilities, operating | 4,490 | 6,220 | |||||
| Tax receivable agreement liability | 234,117 | 23,949 | |||||
| Earnout consideration liability | 16,386 | 793 | |||||
| Total liabilities | 720,450 | 406,814 | |||||
| Commitments and contingencies (Note 13) | |||||||
| Redeemable non-controlling interest | — | 596,587 | |||||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding | — | — | |||||
| Class A common stock, $0.0001 par value; 250,000,000 shares authorized, 82,677,354 and 19,415,123 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. | 8 | 2 | |||||
| Class B common stock, $0.0001 par value; 75,000,000 shares authorized, no shares and 59,958,422 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. | — | 6 | |||||
| Additional paid-in capital | 180,356 | 39,466 | |||||
| Accumulated other comprehensive income | 2,569 | 4,991 | |||||
| Accumulated deficit | (467,942 | ) | (846,825 | ) | |||
| Total stockholders' deficit | (285,009 | ) | (802,360 | ) | |||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ | 435,441 | $ | 201,041 | |||
| Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited) | |||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Net sales | $ | 107,135 | $ | 96,886 | $ | 319,712 | $ | 290,729 | |||||||
| Operating expenses: | |||||||||||||||
| Cost of sales | 51,727 | 47,990 | 153,019 | 134,542 | |||||||||||
| Selling, general and administrative expenses | 26,316 | 20,095 | 74,673 | 67,627 | |||||||||||
| Total operating expenses | 78,043 | 68,085 | 227,692 | 202,169 | |||||||||||
| Income from operations | 29,092 | 28,801 | 92,020 | 88,560 | |||||||||||
| Total other income (expense), net | (113,937 | ) | 10,197 | (126,773 | ) | (6,408 | ) | ||||||||
| (Loss) income before income taxes | (84,845 | ) | 38,998 | (34,753 | ) | 82,152 | |||||||||
| Income tax (expense) | (629 | ) | (949 | ) | (51 | ) | (656 | ) | |||||||
| Net (loss) income | $ | (85,474 | ) | $ | 38,049 | $ | (34,804 | ) | $ | 81,496 | |||||
| Net (loss) income attributable to redeemable non-controlling interests | $ | (43,414 | ) | $ | 30,574 | $ | (18,414 | ) | $ | 65,653 | |||||
| Net (loss) income attributable to CompoSecure, Inc. | $ | (42,060 | ) | $ | 7,475 | $ | (16,390 | ) | $ | 15,843 | |||||
| Net (loss) income per share attributable to Class A common stockholders - basic | $ | (1.10 | ) | $ | 0.39 | $ | (0.58 | ) | $ | 0.86 | |||||
| Net (loss) income per share attributable to Class A common stockholders - diluted | $ | (1.10 | ) | $ | 0.34 | $ | (0.58 | ) | $ | 0.75 | |||||
| Weighted average shares used to compute net (loss) income per share attributable to Class A common stockholders - basic (in thousands) | 38,212 | 19,075 | 28,110 | 18,420 | |||||||||||
| Weighted average shares used to compute net (loss) income per share attributable to Class A common stockholders - diluted (in thousands) | 38,212 | 35,765 | 28,110 | 35,362 | |||||||||||
| Consolidated Statements of Cash Flows (in thousands) (unaudited) | |||||||
| Nine months ended September 30, | |||||||
| 2024 | 2023 | ||||||
| Cash flows from operating activities: | |||||||
| Net (loss) income | $ | (34,804 | ) | $ | 81,496 | ||
| Adjustments to reconcile net income to net cash provided | |||||||
| by operating activities | |||||||
| Depreciation and amortization | 6,932 | 6,249 | |||||
| Stock-based compensation expense | 15,269 | 13,052 | |||||
| Amortization of deferred finance costs | 958 | 1,262 | |||||
| Loss on extinguishment of debt | 148 | — | |||||
| Change in fair value of earnout consideration liability | 34,060 | (10,540 | ) | ||||
| Revaluation of warrant liability | 76,211 | (1,771 | ) | ||||
| Change in fair value of derivative liability | (425 | ) | 364 | ||||
| Deferred tax (benefit) | (4,813 | ) | (1,485 | ) | |||
| Changes in assets and liabilities | |||||||
| Accounts receivable | (3,311 | ) | (11,261 | ) | |||
| Inventories | (2,550 | ) | (9,614 | ) | |||
| Prepaid expenses and other assets | (115 | ) | (87 | ) | |||
| Accounts payable | 4,499 | 6,938 | |||||
| Accrued expenses | 1,487 | 4,065 | |||||
| Other liabilities | 590 | (789 | ) | ||||
| Net cash provided by operating activities | 94,136 | 77,879 | |||||
| Cash flows from investing activities: | |||||||
| Purchase of property and equipment | (4,782 | ) | (6,669 | ) | |||
| Capitalized software expenditures | (729 | ) | — | ||||
| Net cash used in investing activities | (5,511 | ) | (6,669 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from employee stock purchase plan, warrants and exercises of equity awards | 2,895 | 1,024 | |||||
| Payments for taxes related to net share settlement of equity awards | (8,482 | ) | (3,126 | ) | |||
| Payment of tax receivable agreement liability | — | (2,193 | ) | ||||
| Payment of term loan | (10,333 | ) | (18,122 | ) | |||
| Deferred finance costs related to debt modification | (1,889 | ) | (256 | ) | |||
| Tax distributions to non-controlling members | (34,863 | ) | (38,362 | ) | |||
| Special distribution to non-controlling members | (15,573 | ) | — | ||||
| Dividend to Class A shareholders | (8,922 | ) | — | ||||
| Net cash used in financing activities | (77,167 | ) | (61,035 | ) | |||
| Net increase in cash and cash equivalents | 11,458 | 10,175 | |||||
| Cash and cash equivalents, beginning of period | 41,216 | 13,642 | |||||
| Cash and cash equivalents, end of period | $ | 52,674 | $ | 23,817 | |||
| Supplementary disclosure of cash flow information: | |||||||
| Cash paid for interest expense | $ | 16,987 | $ | 18,296 | |||
| Supplemental disclosure of non-cash financing activities: | |||||||
| Derivative asset - interest rate swap | $ | (2,422 | ) | $ | (637 | ) | |
| Non-GAAP Adjusted EBITDA Reconciliation (in thousands) (unaudited) | ||||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | |||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||
| (in thousands) | ||||||||||||||||
| Net (loss) income | $ | (85,474 | ) | $ | 38,049 | $ | (34,804 | ) | $ | 81,496 | ||||||
| Add: | ||||||||||||||||
| Depreciation and amortization | 2,331 | 2,078 | 6,932 | 6,249 | ||||||||||||
| Interest expense, net (1) | 5,533 | 6,010 | 16,927 | 18,355 | ||||||||||||
| Income tax expense | 629 | 949 | 51 | 656 | ||||||||||||
| EBITDA | $ | (76,981 | ) | $ | 47,086 | $ | (10,894 | ) | $ | 106,756 | ||||||
| Stock-based compensation expense | 5,634 | 4,637 | 15,269 | 13,052 | ||||||||||||
| Mark-to-market adjustments, net (2) | 108,404 | (16,207 | ) | 109,846 | (11,947 | ) | ||||||||||
| Secondary offering transaction costs | — | — | 586 | — | ||||||||||||
| Debt refinance costs | 225 | — | 225 | — | ||||||||||||
| Resolute transaction costs | 2,726 | — | 2,726 | — | ||||||||||||
| Adjusted EBITDA | $ | 40,008 | $ | 35,516 | $ | 117,758 | $ | 107,861 | ||||||||
(1) Includes amortization of deferred financing cost for the three and nine months ended September 30, 2024 and 2023, respectively.
(2) Includes the changes in fair value of warrant liability, derivative liabilities and earnout consideration liability for the three and nine months ended September 30, 2024 and 2023, respectively.
| Non-GAAP Adjusted EPS Reconciliation (in thousands) (unaudited) | |||||||||||||||
| Three months ended September 30, | Nine months ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| (in thousands) except per share amounts | |||||||||||||||
| Basic and Diluted: | |||||||||||||||
| Net (loss) income | $ | (85,474 | ) | $ | 38,049 | $ | (34,804 | ) | $ | 81,496 | |||||
| Add: provision for income taxes | 629 | 949 | 51 | 656 | |||||||||||
| (Loss) income before income taxes | (84,845 | ) | 38,998 | (34,753 | ) | 82,152 | |||||||||
| Income tax expense (1) | (7,100 | ) | (5,868 | ) | (20,487 | ) | (17,639 | ) | |||||||
| Adjusted net (loss) income before adjustments | (91,945 | ) | 33,130 | (55,240 | ) | 64,513 | |||||||||
| (Less) add: mark-to-market adjustments (2) | 108,948 | (16,058 | ) | 110,271 | (12,311 | ) | |||||||||
| Add: secondary offering transaction costs | $ | — | — | 586 | — | ||||||||||
| Add: stock-based compensation | 5,634 | 4,637 | 15,269 | 13,052 | |||||||||||
| Adjusted net income | $ | 25,588 | $ | 21,709 | $ | 73,837 | $ | 65,254 | |||||||
| Common shares outstanding used in computing net income per share, basic: | |||||||||||||||
| Class A and Class B common shares (3) | 82,222 | 79,033 | 81,303 | 78,378 | |||||||||||
| Common shares outstanding used in computing net income per share, diluted: | |||||||||||||||
| Warrants (Public and Private) (4) | 8,094 | 8,094 | 8,094 | 8,094 | |||||||||||
| Equity awards | 3,544 | 3,690 | 2,915 | 3,942 | |||||||||||
| Total Shares outstanding used in computing net income per share - diluted | 93,860 | 90,817 | 92,312 | 90,414 | |||||||||||
| Adjusted net income per share - basic | $ | 0.31 | $ | 0.27 | $ | 0.91 | $ | 0.83 | |||||||
| Adjusted net income per share - diluted | $ | 0.27 | $ | 0.24 | $ | 0.80 | $ | 0.72 | |||||||
1) Calculated using the Company's blended tax rate.
2) Includes the changes in fair value of warrant liability and earnout consideration liability.
3) Assumes both Class A shares and Class B shares participate in earnings and are outstanding at the end of the period.
4) Assumes treasury stock method, valuation at assumed fair market value of $18.00.
5) The Company did not include the effect of Exchangeable Notes in its total shares outstanding used in diluted adjusted net income per share.